| [1]Ware LB,Matthay MA.The acute respiratory distress syndrome[J].N Engl J Med,2000,342(18):1334-1349. [2]Fernandez PC,Nin N,Lorente JA.Acute lung injury and acute respiratory distress syndrome:a genomic perspective[J].Med Intensiva,2011,35(6):361-372. [3]Imai Y,Kuba K,Rao S,et al.Angiotensin-converting enzyme 2 protects from severe acute lung failure[J].Nature,2005,436:112-116. [4]Arndt PG,Young SK,Poch KR,et al.Systemic inhibition of the angiotensin-converting enzyme limits lipopolysaccharide-induced lung neutrophils recruitment through both bradykinin and angiotensin Ⅱ-regulated pathways[J].J Immunol,2006,177:7233-7241. [5]Adamzik M,Frey U,Sixt S,et al.ACE I/D but not AGT(-6)A/G polymorphism is a risk factor for mortality in ARDS[J].Eur Respir J,2007,29(3):482-488. [6]Marshall RP,Webb S,Bellingan GJ,et al.Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome[J].Am J Respir Crit Care Med,2002,166:646-650. [7]Jerng JS,Yu CJ,Wang HC,et al.Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome[J].Crit Care Med,2006,34:1001-1006. [8]Lu XM,Chen GJ,Yang Y,et al.Angiotensin-converting enzyme polymorphism affect outcome of local Chinese with acute lung injury[J].Respiratory Medicine,2011,105:1485-1490. [9]Matsuda A,Kish T,Jacob A,et al.Association between insertion/deletion polymorphism in Angiotensin-converting enzyme gene and acute lung injury/acute respiratory distress syndrome:a meta-analysis[J].BMC Medical Genetics,2012,13:76. [10]Bowler RP,Nicks M,Tran K,et al.Extracellular superoxide dismutase attenuates lipopolysaccharide induced neutrophilic inflammation[J].Am J Respir Cell Mol Biol,2004,31:432-439. [11]Arcaroli JJ,Hokanson JE,Abraham E,et al.Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality[J].Am J Respir Crit Care Med,2009,179:105-112. [12]Crawley E,Kay R,Sillibourne J,et al.Polymorphic haplotypes of the interleukin-10 5′flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile arthritis[J].Arthritis Rheum,1999,42:1101-1108. [13]Gong MN,Thompson BT,Williams PL,et al.Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome[J].Eur Respir J,2006,27:674-681. [14]Wainwright MS,Rossi J,Schavocky J,et al.Protein kinase involved in lung injury susceptibility:evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment[J].Proc Natl Acad Sci USA,2003,100:6233-6238. [15]Eutamene H,Theodorou V,Schmidlin F,et al.LPS-induced lung inflammation is linked to increased epithelial permeability:role of MLCK[J].Eur Resp J,2005,25:789-796. [16]Gao L,Grant A,Halder I,et al.Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury[J].Am J Respir Cell Mol Biol,2006,34:487-495. [17]Christie JD,Ma SF,Aplenc R,et al.Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma[J].Crit Care Med,2008,36:2794-2800. [18]Marzec JM,Christie JD,Reddy SP,et al.Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury[J].FASEB J,2007,21:2237-2246. [19]Ye SQ,Simon BA,Maloney JP,et al.Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury[J].Am J Respir Crit Care Med,2005,171:361-370. [20]Bajwa EK,Yu CL,Gong MN,et al.Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome[J].Crit.Care Med,2007,35:1290-1295. [21]Eisner MD,Parsons PE,Matthay MA,et al.Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury[J].Thorax,2003,58:983-988. [22]Floros J,Veletza SV,Kotikalapudi P,et al.Dinucleotide repeats in the human surfactant protein-B gene and respiratory distress syndrome[J].Biochem J,1995,305:583-590. [23]Gong MN,Wei Z,Xu LL,et al.Polymorphism in the surfactant protein-B gene,gender,and the risk of direct pulmonary injury and ARDS[J].Chest,2004,125:203-211. [24]Currier PF,Gong MN,Zhai R,et al.Surfactant protein-B polymorphisms and mortality in the acute respiratory distress syndrome[J].Crit Care Med,2008,36:2511-2516. [25]Quasney MW,Waterer GW,Dahmer MK,et al.Association between surfactant protein-B +1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia[J].Crit Care Med,2004,32:1115-1119. [26]Gong MN,Zhou W,Williams PL,et al.308GA and TNFB polymorphisms in acute respiratory distress syndrome[J].Eur Resp J,2005,26:382-389. [27]Corne J,Chupp G,Lee CG,et al.IL-13 stimulates vascular endothelial growth factor and protects against hyperoxic lung injury[J].J Clin Invest,2000,106:783-791. [28]Medford AR,Keen LJ,Bidwell JL,et al.Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome[J].Thorax,2005,60:244-248. [29]Zhai R,Gong MN,Zhou W,et al.Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS[J].Thorax,2007,62:718-722. [30]Gong MN.Genetic epidemiology of acute respiratory distress syndrome:implication for future prevention and treatment[J].Clin Chest Med,2006,27(4):705-724. [31]董化江,罗悦晨,高富合,等.急性呼吸窘迫综合症患者的液体管理[J].武警医学院学报,2011,20(7):535-537. [32]王春梅,张培荣,张勇,等.纤溶酶原激活物抑制物-1与急性脑梗死并发急性肺损伤/急性呼吸窘迫综合征的相关性研究[J].实用临床医药杂志,2012,16(24):23-25. |